The California Department of Health has issued an All Facilities Letter regarding the recall of Heparin products due to reported adverse reactions in patients. These reactions include acute hypotension and anaphylactic type reactions. The contamination of raw materials used to produce the products is believed to be the cause of these reactions. Healthcare facilities, including nursing homes, are requested to review all drug storage areas and ensure that all recalled Heparin has been removed and is no longer available for patient use. The manufacturers involved in the recall are Baxter International, B. Braun, American Health Packaging (AHP), and Covidien. Facilities can obtain a list of affected products and lot numbers from their suppliers or the FDA website. Compliance with this recall is essential to ensure patient safety and avoid potential consequences for non-compliance.

Summaries are generataed using AI. Check important information.